Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B6453 (±)-Anatoxin A fumarateSummary: nicotinic agonist
- B6465 ICI 162,846Summary: histamine H2 receptor antagonist
- B6471 Oxotremorine sesquifumarateSummary: Muscarinic agonist
- B6492 (RS)-(±)-SulpirideSummary: D2-like dopamine receptor antagonist
- B6505 SKF 38393 hydrobromideSummary: D1-like dopamine receptor partial agonist
- B6527 Tacrine hydrochlorideSummary: cholinesterase inhibitor
- B6579 Oxotremorine MSummary: Muscarinic receptor agonist
- B6582 Pirenzepine dihydrochlorideSummary: M1 muscarinic receptor selective antagonist
- B6586 (-)-Lobeline hydrochlorideSummary: nicotinic receptor partial agonist
- B6623 [Sar9,Met(O2)11]-Substance PSummary: NK1 tachykinin receptor agonist